Clinical Trials Directory

Trials / Unknown

UnknownNCT05332665

AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification

Anterior Segment Optical Coherence Tomography Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification and YAG Laser Iridotomy, Comparative Study

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the effect of phacoemulsification and YAG Laser peripheral iridotomy on the anterior chamber angle anatomic parameters in PACG eyes, using anterior segment optical coherence tomography (SS ASOCT) device

Detailed description

The recent treatment of ACG is phacoemulsification in patients of acute attack with YAG laser iridotomy in the other eye. The AS-OCT will be used for evaluation of the angle of the anterior chamber parameters in both eyes after phacoemulsification and YAG laser peripheral iridotomy. Follow up of AS-OCT will be done 1,3,6 months after surgery and we will compare results in each eye and between both eyes. .

Conditions

Interventions

TypeNameDescription
DEVICEAS-OCTAnterior segment optical coherence tomography (AS OCT) is an imaging device that can acquire an anterior segment image using a noncontact method with the patient in a sitting position. This device provides reproducible and quantitative measurements of the AC angle and other anterior segment parameters.
PROCEDUREYAG laser PImedical procedure which uses a laser device to create a hole in the iris, thereby allowing aqueous humor to traverse directly from the posterior to the anterior chamber and, consequently, relieve a pupillary block

Timeline

Start date
2022-01-11
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2022-04-18
Last updated
2022-04-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05332665. Inclusion in this directory is not an endorsement.